R&D Changing Faces - Pharma and biotech - October 2025 From high-profile resignations to strategic appointments, October was a buzzy month for pharma industry personnel news.
R&D Beyond animal testing: How human data trials are reshaping d... Researchers are beginning to imagine a future in which development pipelines are more predictive, more efficient, and ultimately more humane.
R&D From physics to pharma: How Aqemia is reinventing the future... The UK life sciences sector has long been a crucible for innovation, blending academic excellence with a thriving ecosystem of biotech and pharmaceutical enterprises.
R&D Sponsored 12 Questions With Trenton M. Johnson Find out more about Senior Director of CMC Portfolio Management, Thermo Fisher Scientific, Trenton M. Johnson in a new 12 Questions With.
R&D Leveraging AI agents to eliminate ‘white space’ in clinical ... Human-AI collaboration has the potential to mitigate gross productivity gaps and establish a new standard of clinical trial efficiency.
R&D ESMO25: On partnerships between pharma and diagnostic develo... Jane Li, Senior Director of Pharma CDx and CRO Partnership, Clinical Next Generation Sequencing Business, at Thermo Fisher Scientific discusses CDx.
News ESMO26: Bayer's Nubeqa finds new prostate cancer role Bayer's prostate cancer drug Nubeqa has reduced the risk of the disease spreading or death by 58% in patients at high risk of disease recurrence.
Digital Sponsored Discover a new era of healthcare panel engagement: Grounded ... A new webinar from Konovo will address some of the critical topics impacting today’s healthcare market research industry.
